338 related articles for article (PubMed ID: 28714689)
21. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
22. Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia.
Hu MH; Yu BY; Wang X; Jin G
Bioorg Chem; 2020 Nov; 104():104264. PubMed ID: 32920366
[TBL] [Abstract][Full Text] [Related]
23. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
24. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
25. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
26. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
27. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo.
Yang J; Cao C; Luo D; Lan S; Luo M; Shan H; Ma X; Liu Y; Yu S; Zhong X; Li R
Eur J Med Chem; 2020 Jul; 198():112336. PubMed ID: 32387836
[TBL] [Abstract][Full Text] [Related]
29. A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of c-MYC G-quadruplex and Down-regulates c-MYC Transcription in Human Cancer Cells.
Panda D; Debnath M; Mandal S; Bessi I; Schwalbe H; Dash J
Sci Rep; 2015 Aug; 5():13183. PubMed ID: 26286633
[TBL] [Abstract][Full Text] [Related]
30. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
31. Curcumin arrests G-quadruplex in the nuclear hyper-sensitive III
Roy A; Chatterjee O; Banerjee N; Roychowdhury T; Dhar G; Mukherjee G; Chatterjee S
J Biomol Struct Dyn; 2022; 40(20):10203-10219. PubMed ID: 34192476
[No Abstract] [Full Text] [Related]
32. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
Zhang Z; He X; Yuan G
Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
[TBL] [Abstract][Full Text] [Related]
33. Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements.
Postel EH; Berberich SJ; Rooney JW; Kaetzel DM
J Bioenerg Biomembr; 2000 Jun; 32(3):277-84. PubMed ID: 11768311
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the
Han Y; Buric A; Chintareddy V; DeMoss M; Chen L; Dickerhoff J; De Dios R; Chand P; Riggs R; Yang D; Cushman M
J Med Chem; 2024 May; 67(9):7006-7032. PubMed ID: 38668707
[TBL] [Abstract][Full Text] [Related]
35. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
Kang HJ; Park HJ
Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
[TBL] [Abstract][Full Text] [Related]
36. Curcumin analogs exhibit anti-cancer activity by selectively targeting G-quadruplex forming c-myc promoter sequence.
Pandya N; Khan E; Jain N; Satham L; Singh R; Makde RD; Mishra A; Kumar A
Biochimie; 2021 Jan; 180():205-221. PubMed ID: 33188859
[TBL] [Abstract][Full Text] [Related]
37. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers.
Nowar RM; A Osman EE; Abou-Seri SM; El Moghazy SM; Abou El Ella DA
Future Med Chem; 2018 May; 10(10):1191-1205. PubMed ID: 29749767
[TBL] [Abstract][Full Text] [Related]
39. G-Quadruplex-Binding Small Molecule Induces Synthetic Lethality in Breast Cancer Cells by Inhibiting c-MYC and BCL2 Expression.
Paul R; Das T; Debnath M; Chauhan A; Dash J
Chembiochem; 2020 Apr; 21(7):963-970. PubMed ID: 31621996
[TBL] [Abstract][Full Text] [Related]
40. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]